- Filed
- Mar 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Mar 13, 2025 | 17.32M sh |
| Shares Diluted | Q2 2025 · Jan 31, 2025 | 12.15M sh |
| Shares Diluted | Q2 2025 · Jan 31, 2025 | 12.15M sh |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 9.63M sh |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 9.63M sh |
| Operating Cash Flow | Q2 2025 · Jan 31, 2025 | −$1.2M |
| Operating Cash Flow restated | Q2 2025 · Jan 31, 2024 | −$17.41K |
| Short Term Debt | Q2 2025 · Jan 31, 2025 | $250K |
| Cash And Equivalents | Q2 2025 · Jan 31, 2025 | $5.27M |
| Cash And Equivalents | Q2 2025 · Jul 31, 2024 | $1.25M |
| Stockholders Equity | Q2 2025 · Jan 31, 2025 | $7.87M |
| Stockholders Equity | Q2 2025 · Oct 31, 2024 | $5M |
| Stockholders Equity | Q2 2025 · Jul 31, 2024 | $1.75M |
| Stockholders Equity | Q2 2025 · Jan 31, 2024 | $506.25K |
| Stockholders Equity | Q2 2025 · Oct 31, 2023 | $913.89K |
| Stockholders Equity | Q2 2025 · Jul 31, 2023 | $1.54M |
| Current Liabilities | Q2 2025 · Jan 31, 2025 | $770.93K |
| Current Liabilities | Q2 2025 · Jul 31, 2024 | $988.42K |
| Total Liabilities | Q2 2025 · Jan 31, 2025 | $770.93K |
| Total Liabilities | Q2 2025 · Jul 31, 2024 | $1.26M |
| Current Assets | Q2 2025 · Jan 31, 2025 | $8.64M |
| Current Assets | Q2 2025 · Jul 31, 2024 | $2.9M |
| Total Assets | Q2 2025 · Jan 31, 2025 | $8.64M |
| Total Assets | Q2 2025 · Jul 31, 2024 | $3.01M |
| Eps Diluted | Q2 2025 · Jan 31, 2025 | −$0.16 |
| Eps Diluted | Q2 2025 · Jan 31, 2025 | −$0.19 |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | −$0.04 |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | −$0.11 |
| Eps Basic | Q2 2025 · Jan 31, 2025 | −$0.16 |
| Eps Basic | Q2 2025 · Jan 31, 2025 | −$0.19 |
| Eps Basic | Q2 2025 · Jan 31, 2024 | −$0.04 |
| Eps Basic | Q2 2025 · Jan 31, 2024 | −$0.11 |
| Sga Expense | Q2 2025 · Jan 31, 2025 | $502.8K |
| Sga Expense | Q2 2025 · Jan 31, 2025 | $951.91K |
| Sga Expense | Q2 2025 · Jan 31, 2024 | $479.52K |
| Sga Expense | Q2 2025 · Jan 31, 2024 | $1.19M |
| Net Income | Q2 2025 · Jan 31, 2025 | −$1.9M |
| Net Income | Q2 2025 · Jan 31, 2025 | −$2.27M |
| Net Income | Q2 2025 · Jan 31, 2024 | −$407.64K |
| Net Income | Q2 2025 · Jan 31, 2024 | −$1.03M |
| Operating Income | Q2 2025 · Jan 31, 2025 | −$350.8K |
| Operating Income | Q2 2025 · Jan 31, 2025 | −$871.91K |
| Operating Income | Q2 2025 · Jan 31, 2024 | −$547.52K |
| Operating Income | Q2 2025 · Jan 31, 2024 | −$1.2M |
| Capex | Q2 2025 · Jan 31, 2024 | $5.09K |